AI Coming for Pharmacy Benefit Managers: Winners and Losers
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
If you’re in your 30s, certain income levels phase out the traditional IRA deduction. This intro explains who qualifies and how to optimize your savings.
15,844 articlesArtificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
A royal birthday, a new portrait, and a nationwide charity gift. Learn practical money moves you can borrow from the ...
X-Energy lands ratings from six major firms, with five Buy or Overweight calls and a top target of $57, as investors ...
Investors face a stark choice in 2026: back an infrastructure-focused sand and logistics player in the Permian or bac...
A sharp 27% drop for AppLovin stock has investors weighing risk and reward. This guide breaks down the business, the ...
A fashion-forward label bends into audio, turning a five-day NYC pop-up into a live case study in branding, spending,...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
A high-profile insider sale by AeroVironment's CEO has investors asking what it means for the stock. This guide break...
Galaxy Research analyst Alex Thorn lifts the odds of the CLARITY Act becoming law in 2026 to 75%, citing a pivotal Se...
In 2026, investors face a choice between rapid disruption and steady government contracts. This article compares Spac...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...
A federal judge in Boston ruled that trump officials were trying to weaponize a Biden-era clause to cut billions in f...